Megan Blewett joined Venrock in 2017 and focuses on biotech and pharmaceutical investments. She worked on the launch of Federation Bio and serves on the board of Iris Medicine, where she is also a co-founder and President. Prior to Venrock, Megan earned a PhD in chemistry as a Hertz Fellow and NSF Fellow with Ben Cravatt at The Scripps Research Institute. Her PhD work helped form the foundation of the biotech company Vividion. Megan received an A.B./A.M. in chemistry from Harvard University, where she worked in the lab of chemistry Nobel Laureate EJ Corey and was awarded the Thomas T. Hoopes Prize for her senior thesis research. Megan has been named to Business Insider’s Under 40 in Biotech and to the Forbes 30 under 30 list for Healthcare.